This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Oct;14(11):1031-1032.

doi: 10.1016/S1470-2045(13)70426-1. Epub 2013 Sep 10.

Low-toxicity treatment for colorectal cancer in elderly people

Stefan Kubicka¹

Affiliations

PMID: 24028812
DOI: 10.1016/S1470-2045(13)70426-1

Comment

Low-toxicity treatment for colorectal cancer in elderly people

Stefan Kubicka. Lancet Oncol. 2013 Oct.

. 2013 Oct;14(11):1031-1032.

doi: 10.1016/S1470-2045(13)70426-1. Epub 2013 Sep 10.

Author

Stefan Kubicka¹

Affiliation

¹ Cancer Center Reutlingen, 72764 Reutlingen, Germany. Electronic address: kubicka_s@klin-rt.de.

PMID: 24028812
DOI: 10.1016/S1470-2045(13)70426-1

No abstract available

PubMed Disclaimer

Comment on

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial.
Cunningham D, Lang I, Marcuello E, Lorusso V, Ocvirk J, Shin DB, Jonker D, Osborne S, Andre N, Waterkamp D, Saunders MP; AVEX study investigators. Cunningham D, et al. Lancet Oncol. 2013 Oct;14(11):1077-1085. doi: 10.1016/S1470-2045(13)70154-2. Epub 2013 Sep 10. Lancet Oncol. 2013. PMID: 24028813 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information